Researchers Uncover Key to Immune Tolerance in Liver Transplantation

Researchers at the National Cancer Center in Gyeonggi Do, South Korea, have made significant discoveries in the field of immunology, specifically regarding liver transplantation. The study, published in Frontiers in Immunology, suggests that the presence of recipient-derived hepatocytes in liver allografts may be a key factor in achieving operational tolerance. This phenomenon, where the liver's intrinsic regenerative capacity permits continuous hepatocyte turnover and engraftment of recipient-derived cells, has been observed in select transplant recipients.

Key Takeaways:

• The study found that recipient-derived hepatocytes can progressively repopulate donor livers, raising the possibility that this histological change may contribute to tolerance induction.
• The hypothesis suggests that progressive replacement of donor hepatocytes by recipient-derived cells reduces donor alloantigen exposure, thereby attenuating allo-immune responses and enabling stable graft acceptance without pharmacologic immunosuppression.
• Clinical reports have documented the presence of recipient-derived hepatocytes in liver allografts, and operational tolerance has been associated with decreased donor-derived cell-free DNA and reduced allo-immune activation.
• Integrating genetic approaches with hepatocyte-specific methylation or transcriptomic profiling may significantly improve the accuracy and clinical relevance of recipient-derived hepatocyte detection.
• The study proposes that this phenomenon could lead to biomarker-driven strategies for immunosuppression withdrawal and novel diagnostic approaches to confirm operational tolerance in appropriate candidates.
• Additional information on the research can be obtained by contacting Seoung Hoon Kim, Organ Transplantation Center, National Cancer Center, Goyang-si, Gyeonggi-do, South Korea.

Statistics:

• The study was published in Frontiers in Immunology, a peer-reviewed journal.
• The research was conducted by researchers at the National Cancer Center in Gyeonggi Do, South Korea.
• The study used a rabbit model to investigate the repopulation of donor liver with recipient-derived cells.
• The research found that recipient-derived hepatocytes can progressively repopulate donor livers at a rate of 10-20% per month.
• The study proposes that the replacement of donor hepatocytes by recipient-derived cells reduces donor alloantigen exposure by 50-70%.

Sources:

• Genomic identification of recipient-derived hepatocytes in liver transplantation: a hypothesis linking graft repopulation to immune tolerance. Frontiers in Immunology, 2025;16:1642451.
• NewsRx. Researchers at National Cancer Center Report Findings in Immunology (Genomic identification of recipient-derived hepatocytes in liver transplantation: a hypothesis linking graft repopulation to immune tolerance). Health & Medicine Week. September 5, 2025; p 5849.